生物标记物在新生儿早发型败血症中早期诊断的发展趋势

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
杨 兰
文章摘要
早发型败血症(Early-Onset Sepsis EOS)在新生儿重症监护病房(Neonatal Intensive Care Unit,NICU)中病死率高,可能对幸存者带来不同程度的长期损失,因此及时诊断和合理使用抗生素对降低EOS相关死亡率和发病率尤为重要。目前早发型败血症的诊断是临床表现、非特异性生物标志物和血培养的组合。传统的生物标志物如降钙素(PCT)、C-反应蛋白(CRP)等敏感性和特异性较差。为了帮助新生儿科医生准确、快速地识别败血症新生儿,需要有足够敏感性和特异性的EOS生物标志物,所以寻找成本效益高、可靠和早期预测因子也成为研究的热点。因此,本文查阅关于EOS的生物学标记物最新文献,并对其相关指标进行检索,为临床早期识别EOS提供更佳的参考指标。
文章关键词
新生儿;早发型败血症;生物标记物;分子技术
参考文献
[1] Anna G S,Asimina T,Sotirios F,et al.Early Diagnosis of Late-Onset Neonatal Sepsis Using a Sepsis Prediction Score[J].Microorganisms, 2023,11(2):235-235.5. [2] J.E M,L.J W,Joseph B,et al.Correction:Neonatal sepsis:need for consensus definition,collaboration and core outcomes[J].Pediatric research,2020,90(1):232-232. [3] Glaser A M,Hughes M L,Jnah A,et al.Neonatal Sepsis:A Review of Pathophysiology and Current Management Strategies[J].Advances in Neonatal Care,2020,21(1):49-60. [4] Ozmeral I O,Ali B.Neonatal Sepsis[J].Sisli Etfal Hastanesi tip bulteni,2020,54(2):142-158. [5] Boscarino G,Migliorino R,Carbone G,et al.Biomarkers of Neonatal Sepsis:Where We Are and Where We Are Going[J].Antibiotics, 2023,12(8):1233. [6] Stoll J B,Hansen I N,Bell F E,et al.Trends in Care Practices,Morbidity,and Mortality of Extremely Preterm Neonates,1993-2012[J]. JAMA,2015,314(10):1039-1051. [7] Ali O,Gamze O,Erbil K,et al.Maternal serum endocan concentrations are elevated in patients with preterm premature rupture of membranes[J].Journal of perinatal medicine,2019,47(5):510-515. [8] R A H,Stephanie M,Hala C.Systematic Review of the Effectiveness of the Neonatal Early-Onset Sepsis Calculator[J].The Journal of perinatal&neonatal nursing,2019,33(1):82-88. [9] Radska M K,Szwed K,Falkowski A,et al.Distribution of Pathogens in Early-and Late-Onset Sepsis Among Preterm Infants:A Decade-Long Study in a Tertiary Referral Neonatal Intensive Care Unit[J].Journal of Clinical Medicine,2024,14(1):5-5. [10] Stoll B J,Puopolo K M,Hansen N I,et al.Early-onset neonatal sepsis 2015 to 2017,the rise of Escherichia coli,and the need for novel prevention strategies[J].JAMA pediatrics,2020,174(7):e200593-e200593. [11] Ruben B,Eyal E,Gil K.Do Neonatal Infections Require a Positive Blood Culture?[J].American journal of perinatology,2020,37(S2):S18-S21. [12] Quispe A M,Soza G,Chirinos M R,et al.Multidrug resistance bacteremia in neonates and its association with late-onset sepsis and Coagulase-negative Staphylococci[J].The Journal of Infection in Develo**Countries,2020,14(11):1256-1263. [13] Shil P K,Majumder B K,Basak A K,et al.Role of White Blood Cell Count,Immature to Total Ratio and C-Reactive Protein in Early Detection of Clinically Suspected Neonatal Sepsis[J].Mymensingh Medical Journal:MMJ,2023,32(3):721-726. [14] 彭海波,詹媛丽,黄宜娥,等.新生儿早发型败血症血液检查指标与预后的相关性研究[J].检验医学与临床,2022,19(20):2842-2845. [15] Preslava G,Alexander B,Zarko Y,et al.Early Diagnostic Markers of Late-Onset Neonatal Sepsis[J].Pediatric reports,2023,15(3):548-559. [16] Gandhi P,Kondekar S.A review of the different haematological parameters and biomarkers used for diagnosis of neonatal sepsis[J]. HEMATOLOGY,2019. [17] Chauhan N,Tiwari S,Jain U.Potential biomarkers for effective screening of neonatal sepsis infections:An overview[J].Microbial Pathogenesis,2017,107234-242. [18] Xu H,Ca D,Zhou L.Diagnostic and prognostic value of PCT and RDW in premature infants with septicemia[J].Medicine, 2024,103(7):e35725-e35725. [19] Tang Y H,Jeng M J,Wang H H,et al.Risk factors and predictive markers for early and late-onset neonatal bacteremic sepsis in preterm and term infants[J].Journal of the Chinese Medical Association,2022,85(4):507-513. [20] Samantha E,Joern-Hendrik W.Procalcitonin versus C-reactive protein:review of kinetics and performance for diagnosis of neonatal sepsis[J].Journal of perinatology:official journal of the California Perinatal Association,2019,39(7):893-903. [21] 庞德,陈寅凤,向娟.白细胞介素-6与降钙素原检测在早发型新生儿败血症筛查中的应用价值[J].当代医药论丛,2024, 22(17):103-106. [22] Naramura T,Imamura H,Yoshimatsu H,Hirashima K,Irie S,Inoue T,et al.The Predictive value of procalcitonin and high-sensitivity C-reactive protein for early bacterial infections in preterm neonates.Neonatology.2021;118:28–36. [23] Zhou Min Z M,Cheng ShuPeng C S P,Yu JiaLin Y J L,et al.Interleukin-8 for diagnosis of neonatal sepsis:a meta-analysis[J].2015. [24] Yan Z,Jie Z,Huiming S,et al.Acute phase reactant serum amyloid A in inflammation and other diseases[J].Advances in clinical chemistry,2019,9025-80. [25] 刘畅.IL-6在新生儿早期的变化趋势及其对新生儿早发型败血症的诊断价值[D].安徽医科大学,2024. [26] Julia E,Bernhard R.Reliability of Interleukin-6 Alone and in Combination for Diagnosis of Early Onset Neonatal Sepsis:Systematic Review[J].Frontiers in Pediatrics,2022,10840778-840778. [27] Schulman,J.;Benitz,W.E.;Profit,J.;Lee,H.C.;Dueñas,G.;Bennett,M.V.;Jocson,M.A.;Schutzengel,R.;Gould,J.B.Newborn Antibiotic Exp- osures and Association with Proven Bloodstream Infection.Pediatrics 2019,144,e20191105. [28] Pospisilova I,Brodska H L,Bloomfield M,et al.Evaluation of presepsin as a diagnostic tool in newborns with risk of early-onset neonatal sepsis[J].Frontiers in Pediatrics,2023,10:1019825. [29] Bellos I,Fitrou G,Daskalakis G,et al.Soluble TREM-1 as a predictive factor of neonatal sepsis:a meta-analysis[J].Inflammation Research,2018,67:571-578. [30] Qin Q,Liang L,**a Y.Diagnostic and prognostic predictive values of circulating sTREM-1 in sepsis:a meta-analysis[J].Infection, Genetics and Evolution,2021,96:105074. [31] 施佳,林雅婷,张潇月,等.血清sTREM-1,sTNFR-Ⅱ联合CF-6对新生儿早发型败血症的诊断和预后评估价值研究[J].Progress in Modern Biomedicine,2024,24(1). [32] Choo Y K,Cho H S,Seo I B,et al.Comparison of the accuracy of neutrophil CD64 and C-reactive protein as a single test for the early detection of neonatal sepsis[J].Korean journal of pediatrics,2012,55(1):11. [33] Cui W,Xu Y,Fang H,et al.Assessment of continuous neutrophil CD64 index measurement for diagnosing sepsis and predicting outcome in a Chinese pediatric intensive care unit:a prospective study[J].Translational pediatrics,2021,10(6):1668. [34] Gupta D V K,Dhaneria D M.Study of serum vitamin d levels and its association with neonatal sepsis among newborns[J].Pediatr Rev Int J Pediatr Res,2020,7(6):242-7. [35] 余盛.NLR及血清25(OH)D水平与足月新生儿早发型败血症相关性分析[D].昆明医科大学,2023. [36] 尉全平,付晓康,苏琴,等.新生儿早发型败血症危险因素及维生素D水平分析[J].河北医科大学学报,2024,45(12):1415-1419. [37] Yilmaz A,Kaya N,Gonen I,et al.Evaluating of neonatal early onset sepsis through lactate and base excess monitoring[J].Scientific Reports,2023,13(1):14837. [38] Rémi P,Sadaf D,Fatemeh A,et al.The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis[J].Frontiers in immunology,2019,10794. [39] ELMeneza S,Bagoury E I,Rayes H,et al.Pentraxin 3 as a marker of early-onset neonatal sepsis.[J].Clinical and experimental pediatrics,2024. [40] Pammi M,Flores A,Versalovic J,et al.Molecular assays for the diagnosis of sepsis in neonates[J].Cochrane Database of Systematic Reviews,2017(2).
Full Text:
DOI